These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37569792)

  • 1. Design, Synthesis, and Biological Evaluation of New Potential Unusual Modified Anticancer Immunomodulators for Possible Non-Teratogenic Quinazoline-Based Thalidomide Analogs.
    Mabrouk RR; Abdallah AE; Mahdy HA; El-Kalyoubi SA; Kamal OJ; Abdelghany TM; Zayed MF; Alshaeri HK; Alasmari MM; El-Zahabi MA
    Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, and biological evaluation of new challenging thalidomide analogs as potential anticancer immunomodulatory agents.
    El-Zahabi MA; Sakr H; El-Adl K; Zayed M; Abdelraheem AS; Eissa SI; Elkady H; Eissa IH
    Bioorg Chem; 2020 Nov; 104():104218. PubMed ID: 32932121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel promising benzoxazole/benzothiazole-derived immunomodulatory agents: Design, synthesis, anticancer evaluation, and in silico ADMET analysis.
    Elkady H; El-Adl K; Sakr H; Abdelraheem AS; Eissa SI; El-Zahabi MA
    Arch Pharm (Weinheim); 2023 Sep; 356(9):e2300097. PubMed ID: 37379240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, anticancer evaluation,
    El-Zahabi MA; Elkady H; Sakr H; Abdelraheem AS; Eissa SI; El-Adl K
    J Biomol Struct Dyn; 2023; 41(24):15106-15123. PubMed ID: 36889930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, and biological evaluation of novel bioactive thalidomide analogs as anticancer immunomodulatory agents.
    Kotb AR; Bakhotmah DA; Abdallah AE; Elkady H; Taghour MS; Eissa IH; El-Zahabi MA
    RSC Adv; 2022 Nov; 12(52):33525-33539. PubMed ID: 36505721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological Activity, Apoptotic Induction and Cell Cycle Arrest of New Hydrazonoyl Halides Derivatives.
    Mohamed MF; Hassaneen HM; Elzayat EM; El-Hallouty SM; El-Manawaty M; Saleh FM; Mohamed Y; El-Zohiry D; Fahmy G; Abdelaal N; Hassanin N; Hossam N
    Anticancer Agents Med Chem; 2019; 19(9):1141-1149. PubMed ID: 30843494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of a novel series of 6,8-dibromo-4(3H)quinazolinone derivatives as anticancer agents.
    Ahmed MF; Youns M
    Arch Pharm (Weinheim); 2013 Aug; 346(8):610-7. PubMed ID: 23873839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, anticancer evaluation, and
    Kotb AR; Abdallah AE; Elkady H; Eissa IH; Taghour MS; Bakhotmah DA; Abdelghany TM; El-Zahabi MA
    RSC Adv; 2023 Apr; 13(16):10488-10502. PubMed ID: 37021105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New thieno[3,2-d]pyrimidine-based derivatives: Design, synthesis and biological evaluation as antiproliferative agents, EGFR and ARO inhibitors inducing apoptosis in breast cancer cells.
    Farghaly AM; AboulWafa OM; Baghdadi HH; Abd El Razik HA; Sedra SMY; Shamaa MM
    Bioorg Chem; 2021 Oct; 115():105208. PubMed ID: 34365057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New [1,2,4]triazolo[4,3-c]quinazoline derivatives as vascular endothelial growth factor receptor-2 inhibitors and apoptosis inducers: Design, synthesis, docking, and antiproliferative evaluation.
    Azab AE; Alesawy MS; Eldehna WM; Elwan A; Eissa IH
    Arch Pharm (Weinheim); 2022 Oct; 355(10):e2200133. PubMed ID: 35822666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Vascular Smooth Muscle and Cancer Cell Proliferation by New VEGFR Inhibitors and Their Immunomodulator Effect: Design, Synthesis, and Biological Evaluation.
    Ran F; Li W; Qin Y; Yu T; Liu Z; Zhou M; Liu C; Qiao T; Li X; Yousef RG; Eissa IH; Khalifa MM
    Oxid Med Cell Longev; 2021; 2021():8321400. PubMed ID: 34745424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, anticancer effect and molecular modeling of new thiazolylpyrazolyl coumarin derivatives targeting VEGFR-2 kinase and inducing cell cycle arrest and apoptosis.
    Mohamed TK; Batran RZ; Elseginy SA; Ali MM; Mahmoud AE
    Bioorg Chem; 2019 Apr; 85():253-273. PubMed ID: 30641320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New bis([1,2,4]triazolo)[4,3-a:3',4'-c]quinoxaline derivatives as VEGFR-2 inhibitors and apoptosis inducers: Design, synthesis, in silico studies, and anticancer evaluation.
    Alanazi MM; Mahdy HA; Alsaif NA; Obaidullah AJ; Alkahtani HM; Al-Mehizia AA; Alsubaie SM; Dahab MA; Eissa IH
    Bioorg Chem; 2021 Jul; 112():104949. PubMed ID: 34023640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, Synthesis, biological Evaluation, and molecular docking studies of novel Pyrazolo[3,4-d]Pyrimidine derivative scaffolds as potent EGFR inhibitors and cell apoptosis inducers.
    Sherbiny FF; Bayoumi AH; El-Morsy AM; Sobhy M; Hagras M
    Bioorg Chem; 2021 Nov; 116():105325. PubMed ID: 34507234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a series of novel 4-anlinoquinazoline derivatives possessing quinazoline skeleton: Design, synthesis, EGFR kinase inhibitory efficacy, and evaluation of anticancer activities in vitro.
    Chang J; Ren H; Zhao M; Chong Y; Zhao W; He Y; Zhao Y; Zhang H; Qi C
    Eur J Med Chem; 2017 Sep; 138():669-688. PubMed ID: 28711702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, Molecular Modeling and Biological Evaluation of 4-Alkoxyquinazoline Derivatives as Novel Inhibitors of VEGFR2.
    Lu L; Zhao TT; Liu TB; Sun WX; Xu C; Li DD; Zhu HL
    Chem Pharm Bull (Tokyo); 2016 Nov; 64(11):1570-1575. PubMed ID: 27568484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and
    Shehta W; Agili F; Farag B; Youssif S; Almehmadi SJ; Elfeky SM; El-Kalyoubi S
    Future Med Chem; 2023 Apr; 15(8):661-677. PubMed ID: 37125606
    [No Abstract]   [Full Text] [Related]  

  • 18. Discovery of new quinoxaline-2(1H)-one-based anticancer agents targeting VEGFR-2 as inhibitors: Design, synthesis, and anti-proliferative evaluation.
    El-Adl K; Sakr HM; Yousef RG; Mehany ABM; Metwaly AM; Elhendawy MA; Radwan MM; ElSohly MA; Abulkhair HS; Eissa IH
    Bioorg Chem; 2021 Sep; 114():105105. PubMed ID: 34175720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New Thalidomide-Resembling Dicarboximides Target ABC50 Protein and Show Antileukemic and Immunomodulatory Activities.
    Cieślak M; Kaźmierczak-Barańska J; Królewska-Golińska K; Napiórkowska M; Stukan I; Wojda U; Nawrot B
    Biomolecules; 2019 Sep; 9(9):. PubMed ID: 31487824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and synthesis of novel quinazoline nitrogen mustard derivatives as potential therapeutic agents for cancer.
    Li S; Wang X; He Y; Zhao M; Chen Y; Xu J; Feng M; Chang J; Ning H; Qi C
    Eur J Med Chem; 2013 Sep; 67():293-301. PubMed ID: 23871909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.